Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Access options for withdrawn motility-modifying agents.

Michael P Jones1

  • 1Division of Gastroenterology and Hepatology, Northwestern University Medical School, Chicago, Illinois, USA.

The American Journal of Gastroenterology
|October 3, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of IV metoclopramide + diphenhydramine on post-concussion symptoms. A secondary analysis of data from an ED-based randomized study.

Headache·2026
Same author

Changes in Psychological States During Instrumented Biofeedback for Dyssynergic Defaecation and Fecal Incontinence Are Associated With Changes in Patient-Reported Outcomes.

Neurogastroenterology and motility·2026
Same author

Hurricanes, Neighborhood Disadvantage, and Cardiopulmonary Health in US Veterans.

JAMA network open·2026
Same author

Gastrointestinal Symptoms and Systemic Comorbidities in Patients With POTS: A Systematic Review and Meta-Analysis.

Neurogastroenterology and motility·2026
Same author

Symptom Patterns Outside the Rome IV Consensus in Eastern and Western Patients With a Disorder of Gut-Brain Interaction.

The American journal of gastroenterology·2026
Same author

Serological and faecal markers of irritable bowel syndrome: a systematic review and meta-analysis.

EBioMedicine·2026
Same journal

Inter and intra-observer agreement for the LST Classification in Large (>2cm) Colorectal Laterally Spreading Tumours.

The American journal of gastroenterology·2026
Same journal

The Safety and Effectiveness of Early Anti-Tumor-Necrosis-Factor Therapy for Penetrating Crohn's Disease Complications in Children.

The American journal of gastroenterology·2026
Same journal

Calendar of Courses, Symposiums and Conferences.

The American journal of gastroenterology·2026
Same journal

Continuing Medical Education Questions: September 2024.

The American journal of gastroenterology·2026
Same journal

Continuing Medical Education Questions: September 2024.

The American journal of gastroenterology·2026
Same journal

Continuing Medical Education Questions: September 2024.

The American journal of gastroenterology·2026
See all related articles

Limited prokinetic therapy options exist for functional digestive disorders. This article explores alternative prescribing methods to safely access these crucial prokinetic agents for improved patient care.

Area of Science:

  • Gastroenterology
  • Pharmacology

Background:

  • Prokinetic therapy for functional digestive disorders faces challenges due to limited available agents.
  • Several effective prokinetic drugs have been withdrawn from the market, restricting treatment options.

Purpose of the Study:

  • To address the scarcity of accessible prokinetic agents for physicians treating motility and functional digestive disorders.
  • To outline safe, alternative prescribing strategies for obtaining commonly inaccessible prokinetic medications.

Main Methods:

  • Review of current therapeutic landscape for prokinetic agents.
  • Exploration of "alternative prescribing approaches" and "off-label" usage guidelines.
  • Discussion of regulatory and safety considerations for accessing restricted medications.

Related Experiment Videos

Main Results:

  • Despite a perceived lack of options, viable prokinetic agents can be accessed.
  • Alternative prescribing methods offer a pathway to utilize effective, though seemingly inaccessible, prokinetic drugs.
  • Physicians can safely navigate the system to obtain necessary prokinetic treatments.

Conclusions:

  • The limited availability of prokinetic agents is not insurmountable.
  • Physicians can employ strategic prescribing to ensure patients receive needed prokinetic therapy.
  • Safe and effective management of digestive motility disorders is achievable through alternative pharmaceutical access routes.